Avidity Biosciences
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Avidity Biosciences's balance sheet done over the years? Its assets were worth $628,555,000 last year, which is less than in the previous period. 20% of Avidity Biosciences’s total assets is currently financed by debt. Its liabilities reached the amount of $127,791,000, which means an increase by 110% compared compared to last year.

Debt to Assets

Avidity Biosciences, Inc. (NASDAQ:RNA): Debt to assets
2018 3982000 45.11M 1132.87%
2019 96907000 162.26M 167.44%
2020 333898000 27.67M 8.29%
2021 427580000 46.15M 10.79%
2022 638800000 60.72M 9.51%
2023 628555000 127.79M 20.33%

RNA Balance Sheet (2018 – 2023)

2023 2022 2021 2020 2019 2018
Assets
Current assets:
Cash and cash equivalents
185.08M340.39M405.54M328.14M94.57M3.09M
Short term investments
410.26M270.33M85.09M6.67M00
Net receivables
1.10M2.1M900K1.2M800K0
Inventory
01-900K-1.2M10
Other current assets
14.85M12.21M5.59M3.53M1.09M0
Total current assets
611.30M622.94M411.14M331.67M95.67M3.24M
Non-current assets:
Property, Plant and Equipment
16.65M15.00M15.58M1.46M631K702K
Goodwill
000000
Intangible assets
000000
Long term investments
0251K251K251K00
Other non-current assets
596K598K599K501K600K38K
Total non-current assets
17.24M15.85M16.43M2.22M1.23M740K
Total assets
628.55M638.8M427.58M333.89M96.90M3.98M
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
28.36M5.04M4.86M3.69M3.84M0
Short term debt
7.27M3.10M1.76M-7.74M2.77M2.74M
Total current liabilities
80.68M51.90M29.65M14.58M10.23M4.61M
Non-current liabilities:
Long term debt
6.21M7.58M9.96M938K2.16M7.57M
Deferred tax
000000
Other non-current liabilities
01.23M6.53M12.15M45K32.91M
Total non-current liabilities
47.11M8.81M16.49M13.08M152.02M40.49M
Total liabilities
127.79M60.72M46.15M27.67M162.26M45.11M
Data sourceData sourceData sourceData source